anti-ALBUMIN antibody product blog
Tags: Antibody; Albumin; Monoclonal Antibody; anti-ALBUMIN antibody;
The ALBUMIN n/a (Catalog #MBS211919) is an Antibody produced from Mouse and is intended for research purposes only. The product is available for immediate purchase. MyBioSource\'s ALBUMIN can be used in a range of immunoassay formats including, but not limited to, ELISA (EIA). Researchers should empirically determine the suitability of the ALBUMIN n/a for an application not listed in the data sheet. Researchers commonly develop new applications and it is an integral, important part of the investigative research process.The ALBUMIN n/a product has the following accession number(s) (GI #127518) (NCBI Accession #P20768.1) (Uniprot Accession #P20768). Researchers may be interested in using Bioinformatics databases such as those available at The National Center for Biotechnology Information (NCBI) website for more information about accession numbers and the proteins they represent. Even researchers unfamiliar with bioinformatics databases will find the NCBI databases to be quite user friendly and useful.
To buy or view more detailed product information and pricing, please click on the technical datasheet page below:
MBS211919 recognises human serum albumin, a 66 kDa protein that binds and transports steroids, fatty acids, metal ions and thyroid hormones. Albumin accounts for approximately 50% of blood serum protein.
Perservative Stabilisers: 0.09% Sodium Azide (NaN3)
Preparation: Ig fraction prepared by sequential precipitation with caprylic acid and ammonium sulphate solution from ascites. Immunogen: Purified human serum albumin
Buffer Solution: Phosphate buffered saline
Target Species: Human. In general, we may offer more than one antibody to a given target to enable options for the researcher. Available antibodies recognizing ALBUMIN are readily searchable from our website. Different antibodies against the same target such as ALBUMIN may be optimized or tested for different applications and species. This enables researchers to select the option that may be best for their model system, to screen more than antibody to determine which one may be best for their model system, as well as to use more than one antibody to follow up on and validate their results.